Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. - Wikidata - wikimedia - TriplyDB

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

http://www.wikidata.org/entity/Q33647383

about

Orbital radiotherapy for adult thyroid eye disease Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management Graves' ophthalmopathy.Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center.Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?Lid lengthening by sclera interposition for eyelid retraction in Graves' ophthalmopathy Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface Thyroid-associated orbitopathy.The eye and thyroid disease.Radiotherapy in the treatment of Graves ophthalmopathy-to do it or not?The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.Does radiotherapy have a role in the management of thyroid orbitopathy? View 1 Quality of life in patients with Graves ophthalmopathy.Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study.Change in quality of life after medical and surgical treatment of graves' ophthalmopathy.Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.Bilateral versus unilateral thyroid eye disease Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.Clinical scoring scales in thyroidology: A compendium.Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study.Hyperthyroid vs hypothyroid eye disease: the same severity and activity.Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.The evolving role of selenium in the treatment of graves' disease and ophthalmopathy.Graves' ophthalmopathy: a review of immunogenetics.Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective Study Thyroid associated orbitopathy.Risk factors for development or deterioration of Graves' ophthalmopathy Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt.Correction of Excyclotropia by Surgery on the Inferior Rectus Muscle in Patients with Thyroid Eye Disease: A Retrospective, Observational Study Corneal astigmatism in Graves' ophthalmopathy.An overview of thyroid eye disease Quality of life in patients with thyroid eye disease.Relationship between Clinical and Immunological Features of Thyroid Autoimmunity and Ophthalmopathy during Pregnancy Planning health care for patients with Graves' orbitopathy.

P2860

Q24201984-401F57EF-BC3E-4C9B-B51F-37ACFFE73C90 Q26774947-D7A5DA9C-74F3-4F20-B4B7-F57B96E92C07 Q26782424-87F11E96-3A7D-4879-87EE-AB44F2040153 Q33581802-CEB5EA30-72B6-44D1-BB4C-183205CE8D1E Q33597076-023BD287-6DB1-4A35-B551-6CFC9F60A432 Q33624477-ADF46906-21B3-4366-A594-7AEE2D02B2A0 Q33648199-9046E80F-5EEE-4E87-8952-5446F4F9BDCF Q33648788-B5DD1F84-A74F-4AD0-9BF8-2C392FA0A5BD Q33802192-EFBA6F3A-AA1D-4C91-889F-42858FA21B2B Q33910021-8EE54418-D5DE-48BC-8013-621DFFB44308 Q34014090-E6BE0246-51A7-49D8-812E-3E54B680B5B5 Q34102362-94AE02B9-879B-4CFF-9687-985DFF91B811 Q34164149-681E5FD3-0526-4E14-8668-E7623A571F4B Q34369480-53AE9C26-4DDB-476E-9DC5-3F0A544A034E Q34394088-3092BCDE-9EB6-449B-8791-7372CBBAA5D2 Q34500982-5296D70A-DC75-46FC-A9EC-204FC7BD00A8 Q34565430-67278F93-6E3B-4F0B-BD17-E63CE8B53B7F Q34747393-F94023D3-2CC6-47E5-B619-723A11618955 Q34893504-8B0B4161-75C1-4578-BC25-3D76186102F0 Q34998187-A720BD7A-4175-4849-9388-82E1AD0DA1FD Q35174246-AFBE3A1B-57D4-482D-A78D-E68C3FD50138 Q35179672-CD9FD051-933C-4F78-BF63-29F6FEB0EED1 Q35205079-F2FEB499-3357-40B8-95EE-B96C07BAB6FC Q35364814-237B1F77-2A90-4444-8DE1-A1CFF16F8386 Q35479930-BC5662C5-188B-442F-97A9-C6568C1A10D9 Q35542692-B4FE1EEF-B615-4360-A4DF-5909BA0B7B18 Q35671939-54E40D99-056C-4ABF-91D5-E9EE2BEFF7D1 Q35725329-F1768351-A731-4621-944A-D1E2003807F0 Q35731002-3AC6D570-D65D-466C-8C18-3C86D57E87FD Q35843186-11720DDF-6A4B-4F47-A8A5-BEC5FF76F1BF Q35919247-BD3F8537-EAE7-44AE-8304-83E7EDE134C4 Q35975724-98E0D816-0CF9-4F3D-9CAD-E72CD691DFB2 Q36014781-F7C6FAC6-F04E-4802-9387-BAE56FFA02BE Q36069781-E9203FE9-51F5-4DC1-9549-E05E77ACDD0F Q36081576-9E406D2B-D187-4ADF-9439-4804DD14C847 Q36104483-8DD0AFED-DADB-4B31-9392-BAEFC3AB9280 Q36305798-916915F0-C1CE-4FDB-8E5B-522A6AA8F1AD Q36400185-E575078C-D4A9-486B-94B8-8C706D50C6C4 Q36423941-4AB7D3FF-FA87-4BC5-AB15-CBDFAA23E252 Q36800348-E62F55F0-2BD6-4DC5-979D-4AC47A0E547E

P2860

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

http://www.wikidata.org/entity/Q33647383

description

1989 nî lūn-bûn

@nan

1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@ast

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@en

type

label

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@ast

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@en

prefLabel

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@ast

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@en

P1433

Q33647383-76158D0D-B761-4C2F-BBA8-B80515E70E76

P1476

Q33647383-F80142C9-EB74-4248-B751-34E6D05EA998

P2093

Q33647383-118D9D8C-2404-4AF8-BA8E-F71D0BCB8331

Q33647383-19378EFA-B83E-4CE0-8E69-98F8EF16A65E

Q33647383-43742AB0-CF42-4241-87C6-93F82223692F

Q33647383-600A4923-EAD0-4FE7-A677-1AAF980FDCE9

Q33647383-6159A16B-B39B-4EC6-B01F-4C54F78F72A4

Q33647383-F4A2376A-C55C-40F0-997A-93EE59B39395

P2860

Q33647383-58EE4F07-5030-49AB-9646-2E614DEA9C7C

Q33647383-8060A3F8-1B4B-4E9A-8520-3F3F13C674D6

Q33647383-8710BE7E-FCF2-43DF-8495-FEC2F70EF117

Q33647383-9F5B4514-FB82-4447-98D6-172901E450D2

P304

Q33647383-6755FB64-4252-4E0D-A4B3-EB134F6A553A

P31

Q33647383-6A5E3C1E-CEE9-41AE-B85C-00B7F9D8FEFC

P356

Q33647383-984AF4BA-1C78-41D3-A5D6-AF2D81B262D5

P407

Q33647383-1C457A3C-CD59-4407-AF48-D85EBC9AD2D8

P433

Q33647383-0F6894B4-79A5-4A07-BD64-428A95891FE6

P478

Q33647383-19043E6C-3207-414B-B23D-D1E414D64C27

P577

Q33647383-0E7B1590-2158-4EB9-9BB1-D3B64F193CDE

P5875

Q33647383-7B79B8C6-E03D-48A6-9DEE-1F0539856498

P698

Q33647383-B2B0FBFE-0421-4C96-91CF-B7C2643A4DDC

P932

Q33647383-3618090D-ADAF-4C78-82B5-B37854B8E669

P356

P1433

British Journal of Ophthalmology

P1476

Clinical criteria for the asse ...... thalmopathy: a novel approach.

@en

P2093

Berghout A

http://www.w3.org/2001/XMLSchema#string

Koornneef L

http://www.w3.org/2001/XMLSchema#string

Mourits MP

http://www.w3.org/2001/XMLSchema#string

Prummel MF

http://www.w3.org/2001/XMLSchema#string

Wiersinga WM

http://www.w3.org/2001/XMLSchema#string

van der Gaag R

http://www.w3.org/2001/XMLSchema#string

P2860

Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

Graves' ophthalmopathy--immunologic parameters related to corticosteroid therapy.

Orbital compliance in Graves' eye disease.

Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

P304

639-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.73.8.639

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1989-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20391688

http://www.w3.org/2001/XMLSchema#string

P698

2765444

http://www.w3.org/2001/XMLSchema#string

P932

1041835

http://www.w3.org/2001/XMLSchema#string